Avidity Partners Management LP Q2 2022 Filing
Filed August 15, 2022
Portfolio Value
$4.4B
Holdings
82
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (82 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | AZNASTRAZENECA PLC | 3,499,000 | $231.2M | 5.31% | |
| 2 | VRTXVERTEX PHARMACEUTICALS INC | 793,000 | $223.5M | 5.13% | |
| 3 | ARGXARGENX SE | 572,500 | $216.9M | 4.98% | |
| 4 | ELVELEVANCE HEALTH INC | 441,000 | $212.8M | 4.89% | |
| 5 | AVTRAVANTOR INC | 6,652,700 | $206.9M | 4.75% | |
| 6 | LLYLILLY ELI & CO | 610,000 | $197.8M | 4.54% | |
| 7 | HUMHUMANA INC | 412,300 | $193.0M | 4.43% | |
| 8 | UTHUNITED THERAPEUTICS CORP DEL | 725,600 | $171.0M | 3.93% | |
| 9 | JNJJOHNSON & JOHNSON | 900,200 | $159.8M | 3.67% | |
| 10 | HZNPHORIZON THERAPEUTICS PUB L | 1,856,900 | $148.1M | 3.40% | |
| 11 | NBIXNEUROCRINE BIOSCIENCES INC | 1,467,600 | $143.1M | 3.28% | |
| 12 | ARVNARVINAS INC | 3,355,623 | $141.2M | 3.24% | |
| 13 | XBISPDR SER TR | 1,875,000 | $139.3M | 3.20% | |
| 14 | MCKMCKESSON CORP | 388,800 | $126.8M | 2.91% | |
| 15 | UNHUNITEDHEALTH GROUP INC | 242,200 | $124.4M | 2.86% | |
| 16 | ABBVABBVIE INC | 755,000 | $115.6M | 2.65% | |
| 17 | SNDXSYNDAX PHARMACEUTICALS INC | 5,450,000 | $104.9M | 2.41% | |
| 18 | CTLTEURCATALENT INC | 955,000 | $102.5M | 2.35% | |
| 19 | ZNTLZENTALIS PHARMACEUTICALS INC | 3,585,881 | $100.8M | 2.31% | |
| 20 | SGENUSDSEAGEN INC | 550,000 | $97.3M | 2.23% | |
| 21 | BSXBOSTON SCIENTIFIC CORP | 2,525,000 | $94.1M | 2.16% | |
| 22 | BIIBBIOGEN INC | 440,566 | $89.8M | 2.06% | |
| 23 | RAREULTRAGENYX PHARMACEUTICAL IN | 1,479,500 | $88.3M | 2.03% | |
| 24 | ACHCACADIA HEALTHCARE COMPANY IN | 1,035,000 | $70.0M | 1.61% | |
| 25 | NTLAINTELLIA THERAPEUTICS INC | 1,125,194 | $58.2M | 1.34% | |
| 26 | LEGNLEGEND BIOTECH CORP | 1,000,000 | $55.0M | 1.26% | |
| 27 | ARWRARROWHEAD PHARMACEUTICALS IN | 1,438,999 | $50.7M | 1.16% | |
| 28 | IMCRIMMUNOCORE HLDGS PLC | 1,350,000 | $50.4M | 1.16% | |
| 29 | NTRANATERA INC | 1,369,100 | $48.5M | 1.11% | |
| 30 | ITCIEURINTRA-CELLULAR THERAPIES INC | 775,504 | $44.3M | 1.02% | |
| 31 | IDYAIDEAYA BIOSCIENCES INC | 2,972,947 | $41.0M | 0.94% | |
| 32 | BLUBELLUS HEALTH INC NEW | 4,265,000 | $39.4M | 0.90% | |
| 33 | ALTALTIMMUNE INC | 2,981,000 | $34.9M | 0.80% | |
| 34 | KZRKEZAR LIFE SCIENCES INC | 4,050,000 | $33.5M | 0.77% | |
| 35 | RNAAVIDITY BIOSCIENCES INC | 2,080,200 | $30.2M | 0.69% | |
| 36 | KRTXKARUNA THERAPEUTICS INC | 204,570 | $25.9M | 0.59% | |
| 37 | RVMDREVOLUTION MEDICINES INC | 1,325,000 | $25.8M | 0.59% | |
| 38 | ARKGARK ETF TR | 750,000 | $23.6M | 0.54% | |
| 39 | VIRVIR BIOTECHNOLOGY INC | 758,211 | $19.3M | 0.44% | |
| 40 | NKTXNKARTA INC | 1,414,082 | $17.4M | 0.40% | |
| 41 | PHATPHATHOM PHARMACEUTICALS INC | 1,919,800 | $16.2M | 0.37% | |
| 42 | CRBUCARIBOU BIOSCIENCES INC | 2,950,000 | $16.0M | 0.37% | |
| 43 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 1,200,000 | $15.8M | 0.36% | |
| 44 | NUVBNUVATION BIO INC | 4,855,000 | $15.7M | 0.36% | |
| 45 | IOVAIOVANCE BIOTHERAPEUTICS INC | 1,392,300 | $15.4M | 0.35% | |
| 46 | XENEXENON PHARMACEUTICALS INC | 450,000 | $13.7M | 0.31% | |
| 47 | SIBNSI-BONE INC | 1,000,000 | $13.2M | 0.30% | |
| 48 | SPNEUSDSEASPINE HLDGS CORP | 2,010,000 | $11.4M | 0.26% | |
| 49 | ATECALPHATEC HLDGS INC | 1,715,000 | $11.2M | 0.26% | |
| 50 | APLSAPELLIS PHARMACEUTICALS INC | 215,000 | $9.7M | 0.22% | |
| 51 | JAZZJAZZ PHARMACEUTICALS PLC | 62,000 | $9.7M | 0.22% | |
| 52 | NVLSEURALPINE IMMUNE SCIENCES INC | 998,565 | $8.5M | 0.20% | |
| 53 | EPIEURESSA PHARMA INC | 2,460,000 | $7.7M | 0.18% | |
| 54 | IPSCCENTURY THERAPEUTICS INC | 865,000 | $7.3M | 0.17% | |
| 55 | ERASERASCA INC | 995,000 | $5.5M | 0.13% | |
| 56 | CYTCYTEIR THERAPEUTICS INC | 1,850,000 | $5.5M | 0.13% | |
| 57 | ANTXAN2 THERAPEUTICS INC | 688,330 | $5.3M | 0.12% | |
| 58 | CMPXCOMPASS THERAPEUTICS INC | 2,000,000 | $5.3M | 0.12% | |
| 59 | —MEDICUS SCIENCES ACQUISITION | 520,000 | $5.1M | 0.12% | |
| 60 | —BCLS ACQUISITION CORP | 500,000 | $5.0M | 0.11% | |
| 61 | —ARYA SCIENCES ACQU CORP IV | 500,000 | $4.9M | 0.11% | |
| 62 | —PANACEA ACQUISITION CORP II | 500,000 | $4.9M | 0.11% | |
| 63 | SSENTINELONE INC | 204,500 | $4.8M | 0.11% | |
| 64 | OPHTEURIVERIC BIO INC | 430,117 | $4.1M | 0.09% | |
| 65 | —HEALTH SCIENCES ACQ CORP 2 | 400,000 | $4.0M | 0.09% | |
| 66 | TNGXTANGO THERAPEUTICS INC | 813,640 | $3.7M | 0.08% | |
| 67 | HYPRHYPERFINE INC | 1,503,754 | $3.4M | 0.08% | |
| 68 | —CAREMAX INC | 755,329 | $2.7M | 0.06% | |
| 69 | —PHASEBIO PHARMACEUTICALS INC | 4,405,000 | $2.6M | 0.06% | |
| 70 | —FIELD TRIP HEALTH LTD | 2,976,000 | $2.5M | 0.06% | |
| 71 | —ONCOSEC MED INC | 2,945,000 | $2.2M | 0.05% | |
| 72 | OTICEUROTONOMY INC | 1,000,000 | $2.1M | 0.05% | |
| 73 | —SOCIAL CAP SUVRETTA HLD CRPI | 200,000 | $2.0M | 0.05% | |
| 74 | —SOCIAL CAP SUVRETTA HLDS CRP | 200,000 | $2.0M | 0.05% | |
| 75 | GRPHGRAPHITE BIO INC | 710,000 | $2.0M | 0.04% | |
| 76 | —SOCIAL CAP SUVRETTA HLDS CRP | 200,000 | $1.9M | 0.04% | |
| 77 | —SOCIAL CAP SUVRETTA HLDS CP | 200,000 | $1.9M | 0.04% | |
| 78 | SCYXSCYNEXIS INC | 959,524 | $1.8M | 0.04% | |
| 79 | SMFRUSDSEMA4 HOLDINGS CORP | 950,000 | $1.2M | 0.03% | |
| 80 | —SCIENCE 37 HOLDINGS INC | 430,000 | $864K | 0.02% | |
| 81 | NUVB/WSNUVATION BIO INC | 99,999 | $28K | 0.00% | |
| 82 | —MEDICUS SCIENCES ACQUISITION | 57,770 | $10K | 0.00% |